参考文献/References:
[1] Liu Z, Yang Y, He L, et al. High-dose methylprednisolone for acute traumatic spinal cord Injury: A meta-analysis[J]. Neurology,2019,93(9): e841-e850.
[2] Kigerl K A, Mostacada K, Popovich P G. Gut microbiota are disease- modifying factors after traumatic spinal cord injury[J]. Neurotherapeutics, 2018,15(1):60-67.
[3] Ruiz I A, Squair J W, Phillips A A,et al. Incidence and natural progression of neurogenic shock after traumatic spinal cord injury[J]. J Neurotrauma, 2018,35(3):461-466.
[4] Simpson G K,Anderson M I,Daher M,et al. Testing a model of resilience in family members of relatives with traumatic brain injury vs spinal cord injury: multigroup analysis[J]. Archives of Physical Medicine and Rehabilitation, 2021,102(12):2325-2334.
[5] Arran W,Raju D,Christine G,et al. The demographics and traumatic causes of spinal cord injury in Nepal: An observational study[J]. Trauma(London,England),2020,23(4):
146040862094134.
[6] Andresen S R,Biering-Sørensen Fin,Hagen E M, et al. Cannabis use in persons with traumatic spinal cord injury in Denmark[J]. Journal of Rehabilitation Medicine,2017,49(2):152-160.
[7] Dionne A,Richard-Denis A,Lim V,et al. Factors associated with discharge destination following inpatient functional rehabilitation in patients with traumatic spinal cord injury[J]. Spinal Cord,2021,59(6):642-648.
[8] Hayashi T,Fujiwara Y,Sakai H,et al. The time course of dysphagia following traumatic cervical spinal cord injury: a prospective cohort study[J]. Spinal Cord,2020,58(1):53-57.
[9] Richard-Denis A,Chatta R,Thompson C,et al. Patterns and predictors of functional recovery from the subacute to the chronic phase following a traumatic spinal cord injury: a prospective study[J]. Spinal Cord,2020,58(1):43-52.
[10] Mollayeva T,Sutton M,Escobar M,et al. The impact of a comorbid spinal cord injury on cognitive outcomes of male and female patients with traumatic brain injury[J]. PM R,2021, 13(7):683-694.
[11] Simard J M,Chen M,Tarasov K V,et al.Newly expressed SUR1-regulated NC(Ca-ATP)channel mediates cerebral edema after ischemic stroke[J].Nat Med,2006,12(4):433-440.
[12] Meng B,Zhang Q,Huang C,et al.Effects of a single dose of methylprednisolone versus three doses of rosiglitazone on nerve growth factor levels after spinal cord injury[J].J Int Med Res,2011,39(3):805-814.
[13] Kozian R,Schmid G,Demian S. Hypothermia during treat-ment with aripiprazole [J]. Psychiatr Prax,2019,46(1):49-51.
[14] Evaniew N,Belley-Cote E P,Fallah N,et al. Methylpred-nisolone for the treatment of patients with acute spinal cord injuries:a systematic review and meta-analysis [J].J Neurotrau-ma,2016,33(5):468-481.
[15] Gonzalez M,Atidns T, Bierbrauer D,et al.Effect of GM-1 gangfioside an recovery of motor function following nerve root injury in a rat model [J].Reconstr Microsurg,2002,18(7):647.
[16] Fehlings M G.Baptise D C.Current status of clinical trials for acute spinal cord injury [J].J Injure,2005,36(Suppl 2):113-122.
[17] Richard-Denis A,Chatta R. Patterns and predictors of func-tional recovery from the subacute to the chronic phase following a traumatic spinal cord injury: a prospective study[J]. Spinal Cord,2020,58(1):43-52.
[18] Wang P, Lin C, Wu S, et al. Inhibition of autophagy is involved in the protective effects of ginsenoside Rb1 on spinal cord injury[J]. Cell Mol Neurobiol,2018,38(3):679-690.
[19] Gul S,Celik S E,Kalayci M,et al.Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats[J].Surg Neurol,2005,64(4):355-361.
[20] Samantaray S,Das A,Matzelle D C,et al.Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats[J].J Neurochem,2016,136(5):1064-1073.
[21] Chen S,Ye J F,Chen X R,et al. Valproic acid attenuates traumatic spinal cord injury-induced inflammation via STAT1 and NF-κB pathway dependent of HDAC3[J]. Journal of Neuro inflammation,2018,15(1):1-14.
[22] Ko J Y,Choi H. The comparison of recovery patterns between ischemic spinal cord injury and traumatic spinal cord injury from acute to chronic phase[J]. The Journal of Spinal Cord Medicine,2021,44(2):288-298.
[23] JAMES W M, Ryan S. Buspirone for functional improvement after acute traumatic spinal cord injury: a propensity score-matched cohort study[J]. Spinal Cord,2021,59(5):563-570.
[24] Du J, Hao D, He B,et al. Epidemiological characteristics of traumatic spinal cord injury in Xi'an, China[J]. Spinal Cord,2021,59(7):804-813.
[25] Chung-Ying T,Thomas N B, Andrew D D, et al. Treatments that are perceived to be helpful for non-neuropathic pain after traumatic spinal cord injury: a multicenter cross-sectional survey.[J]. Spinal Cord,2021,59(5):520-528.
[26] Menacho S T,Floyd C. Current practices and goals for mean arterial pressure and spinal cord perfusion pressure in acute traumatic spinal cord injury: Defining the gaps in knowledge[J]. The Journal of Spinal Cord Medicine,2021,44(3):350-356.
[27] 莫仕安.脊髓损伤的治疗现状和进展[J].医学信息,2015,(28):384-384.
[28] 祁健,张俊江,孟庆溪,等.脊髓损伤的病理变化及治疗进展[J].现代生物医学进展,2017,17(21),4179-4189.